Skip to main content

Gadolinium Enhancing Lesions in Multiple Sclerosis

  • Chapter

Abstract

Contrast-enhanced MR imaging is a sensitive method for detecting active MS lesions. Gadolinium (Gd) enhancement is a marker for bloodbrain barrier breakdown and histologically correlates with the inflammatory phase of lesion development.

Keywords

  • Multiple Sclerosis
  • Glatiramer Acetate
  • Enhance Lesion
  • Deep White Matter
  • Gadolinium Enhance Lesion

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-540-71372-2_3
  • Chapter length: 30 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   179.00
Price excludes VAT (USA)
  • ISBN: 978-3-540-71372-2
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   229.00
Price excludes VAT (USA)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bastianello S, Pozzilli C, Bernardi S et al (1990) Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 40:591–595

    PubMed  CAS  Google Scholar 

  2. Bitsch A, Bruck W (2002) MRI-pathological correlates in MS. Int MSJ 8:89–95

    Google Scholar 

  3. Filippi M, Rovaris M, Rocca MA et al (2001) European/Canadian Glatiramer Acetate Study Group. Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes.” Neurology 57:731–733

    PubMed  CAS  Google Scholar 

  4. He J, Grossman RI, Ge Y et al (2001) Enhancing patterns in multiple sclerosis: evolution and persistence. AJNR Am J Neuroradiol 22:664–669

    PubMed  CAS  Google Scholar 

  5. Kappos L (1999) Multiple sclerosis trials. Lancet 353:2242–2243

    CrossRef  PubMed  CAS  Google Scholar 

  6. Kappos L, Moeri D, Radue EW, Schoetzau A, Jordan P, MAGNIMS (1999) Predictive value of gadolinium-enhanced MRI for relapse rate and in development of disability in multiple sclerosis – a metaanalysis. Lancet 353:964–969

    CrossRef  PubMed  CAS  Google Scholar 

  7. Miller DH, Grossman RI, Reingold SC (1998) The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121:3–24

    CrossRef  PubMed  Google Scholar 

  8. Polman C, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 58:840–846

    CrossRef  PubMed  Google Scholar 

  9. Waesberghe JH van, van Walderveen MA, Castelijns JA et al (1998) Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 19:675–683

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sahraian, M., Radue, EW. (2007). Gadolinium Enhancing Lesions in Multiple Sclerosis. In: Radü, EW., Sahraian, M. (eds) MRI Atlas of MS Lesions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71372-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-71372-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-71371-5

  • Online ISBN: 978-3-540-71372-2

  • eBook Packages: MedicineMedicine (R0)